The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((4'-chloro-3-fluorobiphenyl-4-yl)methyl)piperazine-1-carboxamide ID: ALA1090397
PubChem CID: 46884034
Max Phase: Preclinical
Molecular Formula: C18H19ClFN3O
Molecular Weight: 347.82
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccc(-c2ccc(Cl)cc2)cc1F)N1CCNCC1
Standard InChI: InChI=1S/C18H19ClFN3O/c19-16-5-3-13(4-6-16)14-1-2-15(17(20)11-14)12-22-18(24)23-9-7-21-8-10-23/h1-6,11,21H,7-10,12H2,(H,22,24)
Standard InChI Key: OFDICSWOZIVFQA-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
7.2819 2.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2807 1.4727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9956 1.0598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7120 1.4731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7091 2.3037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9938 2.7128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4221 2.7189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1381 2.3091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9913 3.5378 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.8510 2.7242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5670 2.3144 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8479 3.5492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5678 1.4864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2797 1.0766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9950 1.4883 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9939 2.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2774 2.7286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5659 1.0607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8534 1.4752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1391 1.0640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1380 0.2381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8572 -0.1748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5686 0.2388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4238 -0.1748 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10 12 2 0
11 13 1 0
6 1 1 0
1 2 2 0
5 7 1 0
3 4 2 0
7 8 1 0
11 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
2 18 1 0
6 9 1 0
18 19 2 0
4 5 1 0
19 20 1 0
8 10 1 0
20 21 2 0
2 3 1 0
21 22 1 0
10 11 1 0
22 23 2 0
23 18 1 0
5 6 2 0
21 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 347.82Molecular Weight (Monoisotopic): 347.1201AlogP: 3.26#Rotatable Bonds: 3Polar Surface Area: 44.37Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.82CX LogP: 2.89CX LogD: 2.33Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.89Np Likeness Score: -1.77
References 1. Liu KK, Lefker BA, Dombroski MA, Chiang P, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons CP, Marala R, Brown JA, Kong JX, Lee E, Werner W, Wenzel Z, Giragossian C, Chen H, Coffey SB.. (2010) Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity., 20 (7): [PMID:20202843 ] [10.1016/j.bmcl.2010.01.107 ]